- Home
- HEQ vs DERM Comparison
HEQ vs DERM Comparison
Compare HEQ & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEQ
- DERM
- Stock Information
- Founded
- HEQ 2011
- DERM 2014
- Country
- HEQ United States
- DERM United States
- Employees
- HEQ N/A
- DERM N/A
- Industry
- HEQ Investment Managers
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- HEQ Finance
- DERM Health Care
- Exchange
- HEQ Nasdaq
- DERM Nasdaq
- Market Cap
- HEQ 132.3M
- DERM 116.8M
- IPO Year
- HEQ N/A
- DERM 2021
- Fundamental
- Price
- HEQ $10.42
- DERM $4.83
- Analyst Decision
- HEQ
- DERM Strong Buy
- Analyst Count
- HEQ 0
- DERM 3
- Target Price
- HEQ N/A
- DERM $9.50
- AVG Volume (30 Days)
- HEQ 43.1K
- DERM 110.0K
- Earning Date
- HEQ 01-01-0001
- DERM 11-12-2024
- Dividend Yield
- HEQ 9.78%
- DERM N/A
- EPS Growth
- HEQ N/A
- DERM N/A
- EPS
- HEQ N/A
- DERM N/A
- Revenue
- HEQ N/A
- DERM $57,771,000.00
- Revenue This Year
- HEQ N/A
- DERM N/A
- Revenue Next Year
- HEQ N/A
- DERM $36.49
- P/E Ratio
- HEQ N/A
- DERM N/A
- Revenue Growth
- HEQ N/A
- DERM N/A
- 52 Week Low
- HEQ $9.08
- DERM $2.85
- 52 Week High
- HEQ $11.84
- DERM $8.11
- Technical
- Relative Strength Index (RSI)
- HEQ 30.72
- DERM 37.41
- Support Level
- HEQ $10.90
- DERM $4.88
- Resistance Level
- HEQ $11.06
- DERM $5.19
- Average True Range (ATR)
- HEQ 0.10
- DERM 0.31
- MACD
- HEQ -0.07
- DERM -0.06
- Stochastic Oscillator
- HEQ 0.00
- DERM 7.14
About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest
John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.